methylprednisolone has been researched along with Crow-Fukase Syndrome in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, JL; Han, XH; Jin, ZD; Ma, DL; Xie, WL | 1 |
Higashihara, M; Kaneko, Y; Kurokawa, K; Nozaka, K; Takano, T; Tsujino, S; Watanabe, T; Yoshida, H | 1 |
Arimura, H; Arimura, K; Hokezu, Y; Maruyama, I; Watanabe, O | 1 |
Erbslöh-Möller, B; Perras, B; Sack, K | 1 |
Geniaux, M; Labbe, L; Sibaud, V; Toussaint, P | 1 |
Arimura, K; Hashiguchi, T; Jonosono, M; Maruyama, I; Maruyama, Y; Matsumuro, K; Osame, M; Otsuka, R; Watanabe, O | 1 |
Arimura, K; Hashiguchi, T; Jonosono, M; Kawabata, M; Kitajima, I; Niimi, H; Osame, M | 1 |
1 trial(s) available for methylprednisolone and Crow-Fukase Syndrome
Article | Year |
---|---|
Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome.
Topics: Adenosine Diphosphate; Aged; Anti-Inflammatory Agents; Blood Platelets; Calcium; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphokines; Male; Methylprednisolone; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Count; POEMS Syndrome; Thrombin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
6 other study(ies) available for methylprednisolone and Crow-Fukase Syndrome
Article | Year |
---|---|
Gastromegaly infiltrated with plasma cells: a new feature of organomegaly in patients with POEMS syndrome.
Topics: Aged; Anti-Inflammatory Agents; Cyclophosphamide; Female; gamma-Globulins; Humans; Immunosuppressive Agents; Methylprednisolone; Plasma Cells; POEMS Syndrome | 2010 |
[Fatal case of Crow-Fukase syndrome with kidney failure, acute consciousness disorder and thrombocytopenia].
Topics: Acute Disease; Anti-Inflammatory Agents; Consciousness Disorders; Fatal Outcome; Glomerulonephritis, Membranous; Humans; Male; Methylprednisolone; Middle Aged; POEMS Syndrome; Prednisolone; Thrombocytopenia | 1995 |
[Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Dexamethasone; Endothelial Growth Factors; Humans; Lymphokines; Male; Methylprednisolone; POEMS Syndrome; Prednisolone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
[POEMS syndrome with chronic renal failure].
Topics: Adult; Anti-Inflammatory Agents; Humans; Kidney Failure, Chronic; Male; Methylprednisolone; POEMS Syndrome | 1999 |
[POEMS syndrome revealed by a scleroderma-like skin thickening].
Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Humans; Methylprednisolone; Middle Aged; Plasmapheresis; POEMS Syndrome; Scleroderma, Systemic; Selective Estrogen Receptor Modulators; Skin; Tamoxifen | 2000 |
VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Cytokines; Endothelial Growth Factors; Female; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lymphokines; Methylprednisolone; Middle Aged; POEMS Syndrome; Prednisolone; Tricuspid Valve Insufficiency; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |